Join us for an informal lunch conversation about career paths through academia and industry with three Duke Ph.D. alumni now working at Liquidia. During this discussion, graduate students and postdocs can gain insights on how to succeed in the pharmaceutical industry.
Dr. Geoffrey Hird is Executive Director of Pharmaceutics and CMC at Liquidia Technologies. After completing his Ph.D. at Duke in Chemistry and spending over a decade at Eisai as Principal Scientist for the Formulation and Drug Delivery Technology Group, Geoff became Director of Early Topical Formulation Development at Stiefel, a GSK company. Three years ago, he assumed his current position with Liquidia Technologies leading the Pharmaceutics and CMC function. For the past eight years, he has balanced his industry roles with academic experience as an Adjunct Associate Professor at UNC’s Eshelman School of Pharmacy.
Dr. Christina Hofmann is a Senior Scientist in Pharmaceutical Development at Liquidia Technologies. Chrissy received her BS and MS in Biomedical Engineering at Case Western Reserve University, with a focus on polymer biomaterials. She went on to study particle engineering for pharmaceutical applications at Ferro Corporation, followed by research in a renal nanotechnology lab at the Cleveland Clinic. She returned to school in the Biomedical Engineering Department at Duke, where she received her Ph.D. in 2015. At Duke, she studied tumor delivery of nanoparticles in Dr. Mark Dewhirst’s lab, with significant collaboration with Dr. Mike Therien. At Liquidia, Chrissy works on formulation development while also supporting CMC for clinical-phase projects.
This event is part of the 2018-19 Careers Beyond Academia series, sponsored by The Graduate School, Duke Career Center, and the Office of Postdoctoral Services. Questions? Contact The Graduate School's professional development team at firstname.lastname@example.org.
LocationFrench Family Science Center, Room 1243 Map and directions
- Professional Development
- Professional Adaptability